$160 Million is the total value of GOLDMAN CAPITAL MANAGEMENT INC's 31 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HILL | Sell | Dot Hill Sys Corp | $20,198,000 | -0.3% | 3,300,292 | -13.7% | 12.60% | +6.4% |
| PCYG | Sell | Park City Group Inc. | $9,234,000 | -13.3% | 745,300 | -3.6% | 5.76% | -7.5% |
| TRIB | Sell | Trinity Biotech | $4,798,000 | -19.5% | 265,690 | -14.2% | 2.99% | -14.1% |
| LCUT | Sell | Lifetime Brands Inc | $2,350,000 | -14.4% | 159,128 | -11.4% | 1.47% | -8.6% |
| AAOI | Sell | Applied Optoelectronics Inc. | $2,281,000 | +19.9% | 131,400 | -4.1% | 1.42% | +28.1% |
| CXDO | Sell | Crexendo Inc. | $1,296,000 | -24.3% | 602,600 | -20.8% | 0.81% | -19.2% |
| IZEA | Sell | Izea Inc | $944,000 | -9.7% | 2,247,875 | -14.0% | 0.59% | -3.6% |
| SLTC | Sell | Selectica Inc | $608,000 | -20.9% | 115,834 | -2.1% | 0.38% | -15.6% |
| ALQA | Sell | Alliqua Inc. | $184,000 | +1.1% | 34,843 | -0.4% | 0.12% | +8.5% |
| PURE | Sell | Pure Biosciences | $175,000 | +9.4% | 240,000 | -4.0% | 0.11% | +17.2% |
| LOCM | Sell | Local Corp | $60,000 | -95.6% | 663,778 | -77.6% | 0.04% | -95.4% |
| Sell | Pivotal Therapeutics Inc. | $46,000 | -29.2% | 979,791 | -9.3% | 0.03% | -23.7% | |
| III | Exit | Information Services Group Inc. | $0 | – | -80,400 | -100.0% | -0.19% | – |
| RCPI | Exit | Rock Creek Pharmaceuticals Inc | $0 | – | -661,000 | -100.0% | -0.97% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-07-30
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Imageware Systems Inc. (IWSY) | 19 | Q4 2017 | 54.4% |
| Icg Group Inc | 19 | Q4 2017 | 11.0% |
| Park City Group Inc. (PCYG) | 19 | Q4 2017 | 7.3% |
| MDC Partners Inc New Cl A Subo (MDCA) | 19 | Q4 2017 | 7.7% |
| Mattersight Corp (MATR) | 19 | Q4 2017 | 7.9% |
| Research Frontiers Inc (REFR) | 19 | Q4 2017 | 7.1% |
| Trinity Biotech (TRIB) | 19 | Q4 2017 | 4.5% |
| Charles & Colvard Ltd (CTHR) | 19 | Q4 2017 | 11.2% |
| Deep Down Inc (DPDW) | 19 | Q4 2017 | 1.4% |
| Crexendo Inc.(CXDO) | 18 | Q3 2017 | 1.2% |
View GOLDMAN CAPITAL MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CYREN Ltd. | February 22, 2016 | 2,092,131 | 5.3% |
| Crexendo, Inc. | February 17, 2015 | 753,054 | 6.7% |
| DOT HILL SYSTEMS CORP | February 17, 2015 | 4,093,317 | 6.8% |
| PHOTOMEDEX INC | January 07, 2015 | 1,050,099 | 5.5% |
| OptimizeRx Corp | October 24, 2014 | 1,532,394 | 6.5% |
| CHARLES & COLVARD LTD | April 03, 2014 | 1,344,494 | 6.7% |
| Bacterin International Holdings, Inc. | December 12, 2013 | 1,500,000 | 2.9% |
| LOCAL Corp | September 26, 2013 | 123 | 0.0% |
| RESEARCH FRONTIERS INC | September 26, 2013 | 1,179,000 | 5.1% |
| TRINITY BIOTECH PLC | January 28, 2013 | 622,000 | 2.9% |
View GOLDMAN CAPITAL MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-02-14 |
| 13F-HR | 2017-11-09 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-09 |
| 13F-HR | 2017-01-19 |
| 13F-HR | 2016-10-31 |
| 13F-HR | 2016-07-29 |
| 13F-HR | 2016-05-13 |
| SC 13G | 2016-02-22 |
| 13F-HR | 2016-02-16 |
View GOLDMAN CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.